PURE Bioscience creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that its distributor, BioTech Medical, LLC, is well-positioned to immediately respond to the current swine flu emergency with its SDC-based SpectraSan 24(TM) disinfectant. SpectraSan 24, which meets the recommendations by the United States Centers for Disease Control (CDC) for infection control for care of patients with confirmed or suspected Swine Influenza A (H1N1) virus in both home and healthcare settings.
Andrea L. Goren, Executive Director of BioTech Medical, LLC, stated, “We are prepared and well-positioned to supply a much needed preventative solution to this potentially dangerous swine flu outbreak. BioTech Medical has a long-term history of successfully selling innovative healthcare products through various market channels and representative groups to multiple segments of the healthcare industry, including hospitals, long-term care facilities, clinics and doctors’ offices throughout the United States as well as internationally.”
Ms. Goren continued, “In addition to our existing marketing organization, we have the staff, warehousing facilities, distribution capability and capital resources to rapidly deliver SpectraSan 24 to all facets of not only healthcare but also institutions, businesses and the hospitality industry. We also have entree into schools, day care, athletic facilities and all modes of transportation such as airlines, cruise lines, rail and bus lines including all regional transit authorities. We also intend to offer SpectraSan 24 directly to consumers and through retail outlets in conjunction with our parent company, SCI Industries.”
According to the CDC, person-to-person transmission of flu occurs mainly through coughing or sneezing of people infected with the influenza virus. People may become infected by touching something with the flu viruses on it and then touching their mouths or noses. Guidance published by the CDC on April 24, 2009 for infection control in healthcare settings advises that “disinfection strategies used during influenza seasons can be applied to the environmental management of swine influenza.” Additional guidance published on April 25, 2009 for infection control in the home recommends keeping “surfaces (especially bedside tables, surfaces in the bathroom, and toys for children) clean by wiping them down with a household disinfectant according to directions on the product label.”
PURE’s SDC-based disinfectants have been registered by the EPA specifically for use on children’s toys, cribs, high chairs and other sensitive areas of the home as well as for use on hard surfaces in multitudes of environments, including hospitals, schools and offices.
SpectraSan 24’s broad spectrum power completely and rapidly eliminates bacteria, fungi and viruses, including Influenza A. SpectraSan 24 also carries a 30-second kill time on standard indicator bacteria, a 24-hour residual kill on standard indicator bacteria, a 2-minute kill time on some resistant strains of bacteria, a 10-minute kill time on fungi, a 30-second kill time on HIV Type I, and 10-minute kill times on other pathogenic viruses. These claims distinguish the efficacy of SpectraSan 24 from many of the leading commercial and consumer products currently on the market, while maintaining lower toxicity ratings. Based on the EPA toxicity ratings from Category I (high toxicity) down to Category IV, SpectraSan 24 is a Category IV antimicrobial for which precautionary labeling statements are not required. This compares with Category II warning statements for most leading brands of disinfectant products.
Source: BioTech Medical, LLC
Web Site: http://www.biotechmedicalllc.com/
